Pulmonary pharmacology and therapeutics

The polyhedric reality of the interaction between COVID-19, asthma and inhaled corticosteroids
Francisco-Javier Gonzalez-Barcala, Juan-Jose Nieto-Fontarigo, Paula Mendez-Brea, Francisco-Javier Salgado

ERJ Open Research Apr 2022, 8 (2) 00179-2022; DOI: 10.1183/23120541.00179-2022
Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
Ian D. Pavord, Roland Buhl, Monica Kraft, Charlene M. Prazma, Robert G. Price, Peter H. Howarth, Steven W. Yancey

ERJ Open Research Apr 2022, 8 (2) 00560-2021; DOI: 10.1183/23120541.00560-2021
Chronic cough in cystic fibrosis: the effect of modulator therapy on objective 24-h cough monitoring
Mengru Zhang, Kayleigh Brindle, Melanie Robinson, Debbie Ingram, Tanya Cavany, Alyn Morice

ERJ Open Research Apr 2022, 8 (2) 00031-2022; DOI: 10.1183/23120541.00031-2022
Novel CFTR modulator combinations maximise rescue of G85E and N1303K in rectal organoids
Marjolein M. Ensinck, Liesbeth De Keersmaecker, Anabela S. Ramalho, Senne Cuyx, Stephanie Van Biervliet, Lieven Dupont, Frauke Christ, Zeger Debyser, François Vermeulen, Marianne S. Carlon

ERJ Open Research Apr 2022, 8 (2) 00716-2021; DOI: 10.1183/23120541.00716-2021
CFTR modulator use and risk of nontuberculous mycobacteria positivity in cystic fibrosis, 2011–2018
Emily E. Ricotta, D. Rebecca Prevots, Kenneth N. Olivier

ERJ Open Research Apr 2022, 8 (2) 00724-2021; DOI: 10.1183/23120541.00724-2021
Use of single-inhaler triple therapy in the management of obstructive airway disease: Indian medical experts’ review
Raja Dhar, Deepak Talwar, Sundeep Salvi, B.V. Muralimohan, Sagar Panchal, Saiprasad Patil, Sagar Bhagat, Nishtha Khatri, Hanmant Barkate

ERJ Open Research Jan 2022, 8 (1) 00556-2021; DOI: 10.1183/23120541.00556-2021
Inhaled anti-asthma therapies following hormone therapy in women: a nationwide cohort study
Erik Soeren Halvard Hansen, Kristian Aasbjerg, Amalie Lykkemark Moeller, Amani Meaidi, Elisabeth Juul Gade, Christian Torp-Pedersen, Vibeke Backer

ERJ Open Research Jan 2022, 8 (1) 00611-2021; DOI: 10.1183/23120541.00611-2021
A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough
Huda Badri, Carmen Gibbard, Dimitra Denton, Imran Satia, Bashar Al-Sheklly, Rachel J. Dockry, Kimberley Holt, Kevin McGuiness, Sam Treadway, Peter Whorwell, Lesley Houghton, Augustine Lee, K. Jane Escott, Theresa Lee, Greame Wilkinson, Alison Holt, Brendan J. Canning, Jacky A. Smith

ERJ Open Research Jan 2022, 8 (1) 00546-2021; DOI: 10.1183/23120541.00546-2021
Comparative safety of inhaled corticosteroids and macrolides in Medicare enrolees with bronchiectasis
Emily Henkle, Charles L. Daley, Jeffrey R. Curtis, Benjamin Chan, Timothy R. Aksamit, Kevin L. Winthrop

ERJ Open Research Jan 2022, 8 (1) 00786-2020; DOI: 10.1183/23120541.00786-2020
Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience
Yochai Adir, Einat Fireman Klein, Walid Saliba

ERJ Open Research Jan 2022, 8 (1) 00014-2022; DOI: 10.1183/23120541.00014-2022

Main menu

User menu

Search

Pulmonary pharmacology and therapeutics

Pages

Contact us